Literature DB >> 11002762

Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.

A G Douglas-Jones1, J M Morgan, M A Appleton, R L Attanoos, A Caslin, C S Champ, M Cotter, N S Dallimore, A Dawson, R W Fortt, A P Griffiths, M Hughes, P A Kitching, C O'Brien, A M Rashid, D Stock, A Verghese, D W Williams, N W Williams, S Williams.   

Abstract

AIM: To determine interobserver and intra-observer agreement in the assessment of cytological grade and intraduct necrosis in pure duct carcinoma in situ (DCIS) of the breast.
METHODS: Sixty unselected cases with illustrated diagnostic criteria were circulated to 19 practising histopathologists.
RESULTS: Overall agreement was moderate for cytological grade in three categories: 71% agreement; weighted kappa (kappa w), 0.36; intraduct necrosis in three categories (absent, present, extensive): 76% agreement; kappa w, 0.57; and the Van Nuys classification system: 73% agreement; kappa w, 0.48. Agreement was no better among observers participating in the National External Quality Assurance Programme. Intra-observer agreement for cytological assessment (69.6% agreement; kappa w, 0.52) and intraduct necrosis (68.3% agreement; kappa w, 0.48) was moderate, suggesting that individual variation rather than precision of criteria contributes to the lack of agreement.
CONCLUSIONS: Moderate agreement on observations can be achieved by non-specialist pathologists, with better agreement on necrosis than cytological grade. There was evidence of consistent individual bias towards over or under scoring cytological grade, which could be corrected with adequate and prompt feedback.

Entities:  

Mesh:

Year:  2000        PMID: 11002762      PMCID: PMC1762937          DOI: 10.1136/jcp.53.8.596

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

Authors:  A G Douglas-Jones; S K Gupta; R L Attanoos; J M Morgan; R E Mansel
Journal:  Histopathology       Date:  1996-11       Impact factor: 5.087

2.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

3.  Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.

Authors:  C O Bellamy; C McDonald; D M Salter; U Chetty; T J Anderson
Journal:  Hum Pathol       Date:  1993-01       Impact factor: 3.466

4.  Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.

Authors:  N Sneige; M D Lagios; R Schwarting; W Colburn; E Atkinson; D Weber; A Sahin; B Kemp; A Hoque; S Risin; A Sabichi; C Boone; K Dhingra; G Kelloff; S Lippman
Journal:  Hum Pathol       Date:  1999-03       Impact factor: 3.466

5.  Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.

Authors:  H F Frierson; R A Wolber; K W Berean; D W Franquemont; M J Gaffey; J C Boyd; D C Wilbur
Journal:  Am J Clin Pathol       Date:  1995-02       Impact factor: 2.493

6.  Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.

Authors:  J P Sloane; R Ellman; T J Anderson; C L Brown; J Coyne; N S Dallimore; J D Davies; D Eakins; I O Ellis; C W Elston
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

Review 7.  Ductal carcinoma in situ: a proposal for a new classification.

Authors:  R Holland; J L Peterse; R R Millis; V Eusebi; D Faverly; M J van de Vijver; B Zafrani
Journal:  Semin Diagn Pathol       Date:  1994-08       Impact factor: 3.464

8.  Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.

Authors:  D N Poller; M J Silverstein; M Galea; A P Locker; C W Elston; R W Blamey; I O Ellis
Journal:  Mod Pathol       Date:  1994-02       Impact factor: 7.842

9.  Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ.

Authors:  M Harrison; J D Coyne; T Gorey; P A Dervan
Journal:  Histopathology       Date:  1996-05       Impact factor: 5.087

10.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

View more
  10 in total

1.  Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.

Authors:  A G Douglas-Jones; J Logan; J M Morgan; R Johnson; R Williams
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

2.  Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.

Authors:  Serdar Altinay; Laurent Arnould; Noella Bletard; Cecile Colpaert; Franceska Dedeurwaerdere; Benjamin Dessauvagie; Valérie Duwel; Giuseppe Floris; Stephen Fox; Clara Gerosa; Shabnam Jaffer; Eline Kurpershoek; Magali Lacroix-Triki; Andoni Laka; Kathleen Lambein; Gaëtan Marie MacGrogan; Caterina Marchió; Dolores Martin Martinez; Sharon Nofech-Mozes; Dieter Peeters; Alberto Ravarino; Emily Reisenbichler; Erika Resetkova; Souzan Sanati; Anne-Marie Schelfhout; Vera Schelfhout; Abeer M Shaaban; Renata Sinke; Claudia Maria Stanciu-Pop; Claudia Stobbe; Carolien H M van Deurzen; Koen Van de Vijver; Anne-Sophie Van Rompuy; Stephanie Verschuere; Anne Vincent-Salomon; Hannah Wen; Hélène Dano; Caroline Bouzin; Christine Galant; Mieke R Van Bockstal
Journal:  Mod Pathol       Date:  2019-09-18       Impact factor: 7.842

3.  Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

Authors:  Karla Kerlikowske; Annette M Molinaro; Mona L Gauthier; Hal K Berman; Fred Waldman; James Bennington; Henry Sanchez; Cynthia Jimenez; Kim Stewart; Karen Chew; Britt-Marie Ljung; Thea D Tlsty
Journal:  J Natl Cancer Inst       Date:  2010-04-28       Impact factor: 13.506

4.  Ductal carcinoma in situ: recent advances and future prospects.

Authors:  Kelly Lambert; Neill Patani; Kefah Mokbel
Journal:  Int J Surg Oncol       Date:  2012-05-17

5.  Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.

Authors:  Fernando Schuh; Jorge Villanova Biazús; Erika Resetkova; Camila Zanella Benfica; Alessandra de Freitas Ventura; Diego Uchoa; Márcia Graudenz; Maria Isabel Albano Edelweiss
Journal:  Diagn Pathol       Date:  2015-07-10       Impact factor: 2.644

6.  The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.

Authors:  J S Thomas; A M Hanby; N Russell; G van Tienhoven; K Riddle; N Anderson; D A Cameron; J M S Bartlett; T Piper; C Cunningham; P Canney; I H Kunkler
Journal:  Breast Cancer Res Treat       Date:  2017-02-11       Impact factor: 4.872

Review 7.  Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?

Authors:  Gábor Cserni; Anita Sejben
Journal:  Pathol Oncol Res       Date:  2019-11-27       Impact factor: 3.201

8.  Deep learning-based grading of ductal carcinoma in situ in breast histopathology images.

Authors:  Suzanne C Wetstein; Nikolas Stathonikos; Josien P W Pluim; Yujing J Heng; Natalie D Ter Hoeve; Celien P H Vreuls; Paul J van Diest; Mitko Veta
Journal:  Lab Invest       Date:  2021-02-19       Impact factor: 5.662

9.  Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.

Authors:  K Jirström; A Ringberg; M Fernö; L Anagnostaki; G Landberg
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

10.  Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports.

Authors:  Carmen van Dooijeweert; Paul J van Diest; Inge O Baas; Elsken van der Wall; Ivette A G Deckers
Journal:  Diagn Pathol       Date:  2020-05-11       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.